Fidelity International’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fidelity International’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,118,702	Closed	-$245M	–	870
2023 Q3	$245M	Sell	2,118,702 -885,261	-29%	-$95.1M	0.29%	98
2023 Q2	$309M	Buy	3,003,963 +36,879	+1%	+$3.89M	0.35%	74
2023 Q1	$324M	Buy	2,967,084 +159,156	+6%	+$17.6M	0.37%	77
2022 Q4	$320M	Buy	2,807,928 +1,759,992	+168%	+$146M	0.38%	68
2022 Q3	$64.9M	Sell	1,047,936 -1,819,157	-63%	-$127M	0.08%	242
2022 Q2	$229M	Buy	2,867,093 +265,303	+10%	+$25.1M	0.27%	98
2022 Q1	$274M	Buy	2,601,790 +770,350	+42%	+$75.1M	0.28%	96
2021 Q4	$197M	Buy	1,831,440 +1,101,141	+151%	+$120M	0.2%	123
2021 Q3	$80M	Buy	730,299 +52,929	+8%	+$5.49M	0.09%	234
2021 Q2	$63.4M	Buy	677,370 +40,067	+6%	+$3.69M	0.07%	266
2021 Q1	$58.7M	Buy	637,303 +45,247	+8%	+$3.82M	0.07%	263
2020 Q4	$43.3M	Sell	592,056 -179,805	-23%	-$13.4M	0.05%	307
2020 Q3	$60M	Buy	771,861 +72,449	+10%	+$4.98M	0.07%	257
2020 Q2	$38.9M	Sell	699,412 -50,801	-7%	-$2.17M	0.05%	285
2020 Q1	$22.2M	Buy	750,213 +40,883	+6%	+$1.38M	0.04%	347
2019 Q4	$25.7M	Buy	709,330 +1,700	+0.2%	+$52.1K	0.04%	364
2019 Q3	$19.3M	Buy	707,630 +2,039	+0.3%	+$52.7K	0.03%	383
2019 Q2	$17M	Buy	705,591 +22,293	+3%	+$565K	0.03%	396
2019 Q1	$18.1M	Buy	683,298 +398,407	+140%	+$9.44M	0.03%	369
2018 Q4	$5.57M	Buy	+284,891	New	+$5.58M	0.01%	499

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fidelity International's HZNP Position: Q4 2023 in Review

Fidelity International sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,118,702 shares — an estimated $245M sold.

Fidelity International first reported a position in HZNP in Q4 2018 and held it in 20 quarters. The position peaked at $324M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Fidelity International reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Fidelity International sold 2,118,702 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $245M.
Fidelity International first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 20 quarters.
Fidelity International's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $324M in Q1 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Fidelity International's 13F filing for Q4 2023, filed 13 Feb 2024.